A
NYSE · Life Sciences Tools & Services
Agilent Technologies Inc
$129.58
-0.06 (-0.05%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 6.90B | 6.86B | 9.44B | 8.58B | 10.41B |
| Net Income | 1.29B | 1.16B | 1.43B | 1.34B | 1.96B |
| EPS | — | — | — | — | — |
| Profit Margin | 18.8% | 17.8% | 15.2% | 15.6% | 18.8% |
| Rev Growth | +0.5% | +0.5% | +8.2% | +1.4% | -2.1% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 6.09B | 6.09B | 15.79B | 17.11B | 16.12B |
| Total Equity | 12.24B | 12.24B | 28.11B | 25.55B | 26.65B |
| D/E Ratio | 0.50 | 0.50 | 0.56 | 0.67 | 0.60 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 1.80B | 1.70B | 3.14B | 2.68B | 2.92B |
| Free Cash Flow | — | — | 1.13B | 652.76M | 1.31B |